These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 15661137)

  • 1. Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening.
    Towner JS; Paragas J; Dover JE; Gupta M; Goldsmith CS; Huggins JW; Nichol ST
    Virology; 2005 Feb; 332(1):20-7. PubMed ID: 15661137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein.
    Ebihara H; Theriault S; Neumann G; Alimonti JB; Geisbert JB; Hensley LE; Groseth A; Jones SM; Geisbert TW; Kawaoka Y; Feldmann H
    J Infect Dis; 2007 Nov; 196 Suppl 2():S313-22. PubMed ID: 17940966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral drug therapy of filovirus infections: S-adenosylhomocysteine hydrolase inhibitors inhibit Ebola virus in vitro and in a lethal mouse model.
    Huggins J; Zhang ZX; Bray M
    J Infect Dis; 1999 Feb; 179 Suppl 1():S240-7. PubMed ID: 9988190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication.
    Hartman AL; Dover JE; Towner JS; Nichol ST
    J Virol; 2006 Jul; 80(13):6430-40. PubMed ID: 16775331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of experimental Ebola Zaire virus infection in BALB/c mice.
    Gibb TR; Bray M; Geisbert TW; Steele KE; Kell WM; Davis KJ; Jaax NK
    J Comp Pathol; 2001 Nov; 125(4):233-42. PubMed ID: 11798240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of high-content imaging assays for lethal viral pathogens.
    Panchal RG; Kota KP; Spurgers KB; Ruthel G; Tran JP; Boltz RC; Bavari S
    J Biomol Screen; 2010 Aug; 15(7):755-65. PubMed ID: 20639507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid and simple detection of Ebola virus by reverse transcription-loop-mediated isothermal amplification.
    Kurosaki Y; Takada A; Ebihara H; Grolla A; Kamo N; Feldmann H; Kawaoka Y; Yasuda J
    J Virol Methods; 2007 Apr; 141(1):78-83. PubMed ID: 17194485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ebola virus: unravelling pathogenesis to combat a deadly disease.
    Hoenen T; Groseth A; Falzarano D; Feldmann H
    Trends Mol Med; 2006 May; 12(5):206-15. PubMed ID: 16616875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of treatment strategies to combat Ebola and Marburg viruses.
    Paragas J; Geisbert TW
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):67-76. PubMed ID: 16441210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology of experimental Ebola virus infection in African green monkeys. Involvement of fibroblastic reticular cells.
    Davis KJ; Anderson AO; Geisbert TW; Steele KE; Geisbert JB; Vogel P; Connolly BM; Huggins JW; Jahrling PB; Jaax NK
    Arch Pathol Lab Med; 1997 Aug; 121(8):805-19. PubMed ID: 9278608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced virus replication, proinflammatory cytokine production, and delayed macrophage cell death in human PBMCs infected with the newly discovered Bundibugyo ebolavirus relative to Zaire ebolavirus.
    Gupta M; Goldsmith CS; Metcalfe MG; Spiropoulou CF; Rollin PE
    Virology; 2010 Jun; 402(1):203-8. PubMed ID: 20394957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evaluation of cyanovirin-N antiviral activity, by use of lentiviral vectors pseudotyped with filovirus envelope glycoproteins.
    Barrientos LG; Lasala F; Otero JR; Sanchez A; Delgado R
    J Infect Dis; 2004 Apr; 189(8):1440-3. PubMed ID: 15073681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence against an important role for infectivity-enhancing antibodies in Ebola virus infections.
    Geisbert TW; Hensley LE; Geisbert JB; Jahrling PB
    Virology; 2002 Feb; 293(1):15-9. PubMed ID: 11853394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of features of pathogenesis in two animal models of Ebola virus infection.
    Ryabchikova EI; Kolesnikova LV; Luchko SV
    J Infect Dis; 1999 Feb; 179 Suppl 1():S199-202. PubMed ID: 9988185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ebola virus defective interfering particles and persistent infection.
    Calain P; Monroe MC; Nichol ST
    Virology; 1999 Sep; 262(1):114-28. PubMed ID: 10489346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Lassa virus and Ebola virus infection in host cells treated with the kinase inhibitors genistein and tyrphostin.
    Kolokoltsov AA; Adhikary S; Garver J; Johnson L; Davey RA; Vela EM
    Arch Virol; 2012 Jan; 157(1):121-7. PubMed ID: 21947546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and characterization of a stable eGFP enterovirus 71 for antiviral screening.
    Shang B; Deng C; Ye H; Xu W; Yuan Z; Shi PY; Zhang B
    Antiviral Res; 2013 Feb; 97(2):198-205. PubMed ID: 23267829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular determinants of Ebola virus virulence in mice.
    Ebihara H; Takada A; Kobasa D; Jones S; Neumann G; Theriault S; Bray M; Feldmann H; Kawaoka Y
    PLoS Pathog; 2006 Jul; 2(7):e73. PubMed ID: 16848640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current knowledge on lower virulence of Reston Ebola virus (in French: Connaissances actuelles sur la moindre virulence du virus Ebola Reston).
    Morikawa S; Saijo M; Kurane I
    Comp Immunol Microbiol Infect Dis; 2007 Sep; 30(5-6):391-8. PubMed ID: 17610952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathologic findings associated with delayed death in nonhuman primates experimentally infected with Zaire Ebola virus.
    Larsen T; Stevens EL; Davis KJ; Geisbert JB; Daddario-DiCaprio KM; Jahrling PB; Hensley LE; Geisbert TW
    J Infect Dis; 2007 Nov; 196 Suppl 2():S323-8. PubMed ID: 17940967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.